HB 928 Pennsylvania House · 2025-2026 Regular Session

An Act amending Title 35 (Health and Safety) of the Pennsylvania Consolidated Statutes, in epinephrine auto-injector entities, further providing for definitions and for epinephrine auto-injectors for authorized entities; and making an editorial change.

HB 928 amends Pennsylvania law to expand access to epinephrine auto-injectors for severe allergic reactions. It adds schools, sports organizations, and other public venues to the list of "authorized entities" allowed to store these devices and train staff. The bill clarifies who can access the injectors during emergencies and specifies training requirements for personnel. This directly affects schools, youth programs, and public facilities serving individuals at risk of anaphylaxis.

Issues: ✓ Healthcare

Bill status passed 3 of 5 stages cleared

Introduction

Mar 2025

Committee Review

Jun 2026

House Passage

Jun 2025

Senate Passage

Governor

Introduced Mar 17, 2025 Last action Jun 29, 2026

Maddy AI version diff · 2 comparisons

What changed between versions

Printer's No. PN1833 → Printer's No. PN1979 · 6 edits

MODERATE

This bill update clarifies definitions for epinephrine delivery systems and expands protections for day-care facilities. It adds specific training requirements for staff and introduces new informational material obligations for day-care centers to ensure parents are informed about allergy policies and emergency procedures.

Scope change

The bill now explicitly includes day-care facilities alongside authorized entities regarding the acquisition, storage, and use of epinephrine delivery systems, and adds specific duties for these facilities regarding staff training and parental communication.

DEFINITION

Added a new definition for 'epinephrine delivery system' to clarify the scope of devices covered beyond just auto-injectors.

REQUIREMENT

Updated storage requirements to specify that devices must be stored according to manufacturer instructions and any additional departmental requirements.

Added a requirement for day-care facilities to designate trained employees or agents responsible for the storage and oversight of epinephrine devices.

Mandated that day-care facilities provide specific informational materials to parents regarding allergy symptoms, facility requirements, and emergency procedures.

TIMELINE

Changed the effective date of the act from 60 days to 180 days.

ENFORCEMENT

Expanded Good Samaritan protections to explicitly include day-care facilities and their staff alongside authorized entities.

Floor votes · House Jun 24, 2025

How they voted

197–6

Passed

Total votes 203

Jun 24, 2025

D Democratic102

102 Yea

100% Yea

R Republican101

95 Yea 6 Nay

94% Yea

Vote distribution

All Yea All Nay Mixed No data

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Amendments

Jun 29, 2026

Committee

Re-referred to Appropriations

upper

Jun 24, 2026

Upper · Passed

Reported as committed

upper

Jun 25, 2025

Committee

Referred to Health & Human Services

upper

Jun 24, 2025

Lower · Passed

Third consideration and final passage

lower

Jun 24, 2025

Lower · Passed

Re-reported as committed

lower

Jun 23, 2025

Committee

Re-committed to Appropriations

lower

Jun 23, 2025

Lower · Passed

Re-reported as committed

lower

Jun 4, 2025

Committee

Re-committed to Rules

lower

Jun 4, 2025

Lower · Passed

Reported as amended

lower

Mar 17, 2025

Committee

Referred to Children & Youth

lower

1 primary · 43 co-sponsors